MedPath

Influence of the Time of Day in the Effect of Caffeine on Maximal Fat Oxidation During Exercise in Women

Not Applicable
Completed
Conditions
Dietary Supplement
Interventions
Dietary Supplement: Acute caffeine supplementation
Registration Number
NCT05880186
Lead Sponsor
Universidad Francisco de Vitoria
Brief Summary

Caffeine is a natural stimulant with well-recognized metabolic benefits, however, there is a lack of studies investigating the time-of-day caffeine influence to enhance fat oxidation in women. The aim of this study was to evaluate the influence of the time of the day on the effect of caffeine on maximal rate of fat oxidation during aerobic exercise in women.

Detailed Description

Caffeine is a natural stimulant with well-recognized sports performance benefits. Aside its performance-enhancing effect, caffeine has the potential of increasing fat utilization during aerobic exercise at submaximal intensities, lowering-down the contribution of carbohydrate as a fuel. This property of caffeine may provoke a glycogen-sparing effect in the skeletal muscle and liver for exercise situations where carbohydrate availability may be a challenge. Additionally, the capacity of caffeine to enhance fat utilization during exercise could be of interest for improving health outcomes as it may increase the rate of change in body composition in exercise programs. Maximal fat oxidation rate (MFO) during exercise is a remarkable physiological indicator associated with metabolic flexibility/body weight loss and endurance performance To date, it is unknown if caffeine increases MFO in the same proportion during morning and evening exercise trials in women. For this reason, the aim of the present study was to evaluate the influence of the time of the day on the effect of caffeine on MFO in women. We hypothesised that caffeine would increase MFO during morning and evening exercise and this effect would be of similar magnitude at both times of day.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
14
Inclusion Criteria
  • To be non-smokers.
  • To have low caffeine intake (i.e., < 50 mg of caffeine per day in the previous 2 months)
  • To show no previous history of cardiopulmonary diseases or having suffered musculoskeletal injuries in the previous 6 months.
  • To have a regular duration of their menstrual cycle for the previous 6 months.
  • To confirm no existence of any type of menstrual disorders such as dysmenorrhea, amenorrhea, or strong symptoms associated with pre-menstrual syndrome.
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Caffeine intakeAcute caffeine supplementationTest in the morning A dose of 3 mg/kg of caffeine (Bulk Powders, Essex, United Kingdom) was ingested before the beginning of each test. Test in the evening A dose of 3 mg/kg of caffeine (Bulk Powders, Essex, United Kingdom) was ingested before the beginning of each test.
Placebo intakeAcute caffeine supplementationTest in the morning A dose of 3 mg/kg of placebo (Cellulose, Guinama, Valencia, Spain) was ingested before the beginning of each test. Test in the evening A dose of 3 mg/kg of placebo (Cellulose, Guinama, Valencia, Spain) was ingested before the beginning of each test
Primary Outcome Measures
NameTimeMethod
MFO2-months

Maximal fat oxidation during exercise

Secondary Outcome Measures
NameTimeMethod
FATmax2-months

The intensity of exercise that elicits MFO

RPE2-months

Rate of percevied exertion during exercise

FAT AND CHO oxidation2-months

Fat and carbohydrates oxidation

Trial Locations

Locations (1)

Universidad Francisco de Vitoria

🇪🇸

Pozuelo De Alarcón, Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath